Will it work?
Can it get approved?
Who will buy it once it’s approved?
These were some of the key questions covered during the Research Session of the second annual Orange County Ophthalmology Technology Summit (OCOTS) hosted by OCTANe. These are indeed some of the most essential questions to consider when preparing to bring any new product to the world. Investors are rightly concerned about functionality, cost-effectiveness, useful applications and the demanding FDA approval process. It’s no surprise that early stage start-ups spend much of their resources perfecting the product.